Cargando…
Intramuscular recurrence in a Hepatocellular carcinoma patient with indolent disease course
BACKGROUND: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options are depended on the stage of the tumour. In general, the prognosis of HCC patients with extra-hepatic metastasis is poor. The most common sites of extra-hepatic metastasis are the lung, abdominal lymph...
Autores principales: | Yau, Thomas, Wong, Hilda, Chan, Pierre, To, MC, Poon, Ronnie T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373298/ https://www.ncbi.nlm.nih.gov/pubmed/18430252 http://dx.doi.org/10.1186/1477-7819-6-42 |
Ejemplares similares
-
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease
por: Yau, Thomas, et al.
Publicado: (2012) -
Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients
por: Ng, Lui, et al.
Publicado: (2019) -
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
por: Yau, Thomas, et al.
Publicado: (2012) -
Solitary Extrahepatic Intramuscular Metastasis from Cryptogenic Hepatocellular Carcinoma
por: Zubair, Talhah, et al.
Publicado: (2018) -
Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
por: Chan, Albert C. Y., et al.
Publicado: (2011)